Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

VI.c

Pleural thickening - Fibrothorax

Oxprenolol was eventually exonerated, as the patient developed malignant mesothelioma

Publications

Page RL

Pleural thickening--oxprenolol exonerated.

British journal of diseases of the chest 1979 Jul;73;319 — 1979 Jul — 319

Page RL

Progressive pleural thickening during oxprenolol therapy.

British journal of diseases of the chest 1979 Apr;73;195-9 — 1979 Apr — 195-9